Brief: GSK Announces Sale Of Stake In Innoviva Inc
May 20 (Reuters) - GlaxoSmithKline PLC GSK.L :
* GSK - GSK ANNOUNCES SALE OF STAKE IN INNOVIVA INC
* GSK - SHARES TO BE SOLD BACK TO INNOVIVA AT $12.25 PER
SHARE
* GSK - GSK WILL NO LONGER HOLD ANY INNOVIVA STOCK.
* GSK - TO SELL ALL OF ITS APPROXIMATELY 32 MILLION SHARES
OF
COMMON STOCK OF INNOVIVA
Further company coverage: GSK.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million